Clinical trial
INST 0514C- Biologic Correlative Study: Trial of GW572016 in HER2 Overexpressing…
NCT00455039 · University of New Mexico, Other · Withdrawn
Key facts
| NCT number | NCT00455039 |
|---|---|
| Title | INST 0514C- Biologic Correlative Study: Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients |
| Official title | INST 0514C- A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study |
| Lead sponsor | University of New Mexico, Other |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | GW572016 |
| Enrollment | 0 |
| Start date | Jul 31, 2023 |
| Primary completion | Jul 31, 2023 |
| Completion | Jul 31, 2023 |
| First posted | Apr 3, 2007 |
| Last update posted | Aug 14, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: